Streptococcal DNase B is immunologically identical to superantigen SpeF but involves separate domains

Clinical and Diagnostic Laboratory Immunology

Volumn 6, Issue 1, 1999, Pages 133-136

  Eriksson, Anna ^a   Eriksson, Björn ^a,b   Holm, Stig E ^a   Norgren, Mari ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE; STREPTOCOCCUS ANTIGEN; STREPTOCOCCUS DEOXYRIBONUCLEASE B; SUPERANTIGEN; SUPERANTIGEN SPEF; UNCLASSIFIED DRUG;

ANTIGEN DETECTION; ARTICLE; ENZYME ANALYSIS; ENZYME INHIBITION; EPITOPE MAPPING; MITOGENICITY; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE; STRUCTURE ANALYSIS;

EID: 0032952152     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.6.1.133-136.1999     Document Type: Article

References (23)

1. Elliot, S. D. 1945. A proteolytic enzyme produced by group A streptococci with special reference to its effect on the type-specific M antigen. J. Exp. Med. 81:573-592.
2. Eriksson, A., S. E. Holm, and M. Norgren. Identification of domains involved in superantigenicity of streptococcal pyrogenic exotoxin F (SpeF). Microb. Pathog., in press.
3. Eriksson, B., J. Andersson, S. E. Holm, and M. Norgren. Epidemiology and clinical aspects of invasive streptococcal infections and the streptococcal toxic shock syndrome. Clin. Infect. Dis., in press.
4. Ferrieri, P. 1986. Immune responses to streptococcal infections, p. 336-341. In N. R. Rose, H. Friedman, and J. L. Fahey (ed.), Manual of clinical immunology, 3rd ed. American Society for Microbiology, Washington, D.C.
5. Hauser, A. R., and P. M. Schlievert. 1990. Nucleotide sequence of the streptococcal pyrogenic exotoxin type B gene and relationship between the toxin and the streptococcal proteinase precursor. J. Bacteriol. 172:4536-4542.
6. Hederstedt, B., S. E. Holm, and R. Norberg. 1980. Extremely high titers of serum antibodies against the streptococcal exoenzyme deoxyribonuclease B. J. Clin. Microbiol. 11:720-723.
7. Herwald, H., M. Collin, W. Muller-Esterl, and L. Björck. 1996. Streptococcal cysteine proteinase releases kinins: a virulence mechanism. J. Exp. Med. 184:665-673.
8. Iwasaki, M., H. Igarashi, Y. Hinuma, and T. Yutsuda. 1993. Cloning, characterization and over-expression of a Streptococcus pyogenes gene encoding a new type of mitogenic factor. FEMS Lett. 331:187-192.
9. Iwasaki, M., H. Igarashi, and T. Yutsuda. 1997. The mitogenic factor (MF) secreted from Streptococcus pyogenes is a heat-stable nuclease requiring His122 for activity. Microbiology 143:2449-2455.
10. Kaplan, E. L., C. D. Rothermel, and D. R. Johnson. 1998. Antistreptolysin O and antideoxyribonuclease B titers: normal values for children ages 2 to 12 in the United States. Pediatrics 101:86-88.
11. Kapur, V., M. W. Majesky, L. Ling-Ling, R. A. Black, and J. M. Musser. 1993. Cleavage of interleukin 1β(IL-1β) precursor to produce active IL-1β by a conserved extracellular cysteine protease from Streptococcus pyogenes. Proc. Natl. Acad. Sci. USA 90:7676-7680.
12. Li, P.-L., R. E. Tiedemann, S. L. Moffat, and J. D. Fraser. 1997. The superantigen streptococcal pyrogenic exotoxin C (SPE-C) exhibits a novel mode of action. J. Exp. Med. 186:375-383.
13. Montecucco, C., and G. Schiavo. 1993. Tetanus toxin and botulinum neurotoxins a new group of zinc proteases. Trends Biochem. Sci. 18:324-327.
14. Norgren, M., and A. Eriksson. 1997. Streptococcal superantigens and their role in the pathogenesis of severe infections. J. Toxicol. Toxin Rev. 16:1-32.
15. Norrby, A., B. Eriksson, M. Norgren, C. Jorup Rönnström, A. C. Sjöblom, K. Karkkonen, and S. E. Holm. 1992. Virulence properties of erysipelas associated group A streptococci. Eur. J. Microbiol. Infect. Dis. 11:1136-1143.
16. Norrby-Teglund, A., D. Newton, M. Kotb, S. E. Holm, and M. Norgren. 1994. Superantigenic properties of the group A streptococcal exotoxin SpeF (MF). Infect. Immun. 62:5227-5233.
17. Norrby-Teglund, A., K. Pauksens, S. E. Holm, and M. Norgren. 1994. Relation between low capacity of human sera to inhibit streptococcal mitogens and serious manifestation of disease. J. Infect. Dis. 170:585-591.
18. Papageorgiou, A. C., K. R. Acharya, R. Shapiro, E. F. Passalacqua, R. D. Brehm, and H. S. Tranter. 1995. Crystal structure of the superantigen enterotoxin C2 from Staphylococcus aureus reveals a zinc-binding site. Structure 3:769-779.
19. Podbielski, A., I. Zarges, A. Flosdorff, and J. Weber-Heynemann. 1996. Molecular characterization of a major serotype M49 group A streptococcal DNase gene (sdaD). Infect. Immun. 64:5349-5356.
20. Renneberg, J., M. Söderström, K. Prellner, A. Forsgren, and P. Christensen. 1989. Age-related variations in anti-streptococcal antibody levels. Eur. J. Clin. Microbiol. Infect. Dis. 8:792-795.
21. 2+-mediated homodimerization. EMBO J. 15:6832-6840.
22. Thompson, G. A., and F. H. Carpenter. 1976. Leucine amino peptidase (bovine lens). The relative binding of cobalt and zinc to leucine amino peptidase and the effect of cobalt substitution on specific activity. J. Biol. Chem. 251:1618-1624.
23. Wolinowska, R., P. Ceglowski, J. Kok, and G. Venema. 1991. Isolation, sequence, and expression in Escherichia coli, Bacillus subtilis, and Lactococcus lactis of the DNase (streptodornase)-encoding gene from Streptococcus equimilis H46A. Gene 106:115-119.